יורוקינאז מדאק 100000 IU
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
UROKINASE
Available from:
TZAMAL BIO-PHARMA LTD
ATC code:
B01AD04
Pharmaceutical form:
אבקה להכנת תמיסה לזריקה
Composition:
UROKINASE 100,000 IU
Administration route:
תוך-ורידי, תוך-עורקי, להחדרה מקומית
Prescription type:
מרשם נדרש
Manufactured by:
MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH, GERMANY
Therapeutic group:
UROKINASE
Therapeutic area:
UROKINASE
Therapeutic indications:
Peripheral arterial thrombosis ;Acute and subacute deep vein thrombosis ; Acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable haemodynamic status ; Thrombosed arteriovenous shunt.
Authorization date:
2015-06-30
